Parasympatholytic classification
Reading File
Finding Sources
Finding Sources
Reading File
Reading File
Reading File
Reading File
Finding Sources
Reading File
Finding Sources
Reading File
Loading Image
Here is a complete classification of parasympatholytic (anticholinergic/antimuscarinic) drugs:
Parasympatholytic Drug Classification
Parasympatholytics (also called anticholinergics or antimuscarinics) are drugs that block muscarinic acetylcholine receptors, thereby inhibiting parasympathetic effects. The term "anticholinergic" technically refers to this muscarinic-blocking group, though a more precise term is antimuscarinic - since they do not block nicotinic receptors at usual clinical doses.
1. By Chemical Structure (Primary Classification)
A. Tertiary Amines (cross the blood-brain barrier - have CNS effects)
| Drug | Source | Key Feature |
|---|---|---|
| Atropine | Natural (belladonna alkaloid) | Most potent cardiac/bronchial effects; racemic mixture |
| Scopolamine | Natural (belladonna alkaloid) | Most potent CNS sedation/antisialagogue; motion sickness prevention |
| Hyoscine | Natural | Same as scopolamine |
| Benztropine | Synthetic | Used in Parkinson's disease |
| Trihexyphenidyl | Synthetic | Antiparkinsonian |
| Pirenzepine | Synthetic | Selective M1 blocker; peptic ulcer |
| Dicycloverine | Synthetic | GI antispasmodic |
| Tropicamide | Synthetic | Ophthalmic use |
B. Quaternary Amines (cannot cross blood-brain barrier - minimal CNS/ophthalmic effects)
| Drug | Key Feature |
|---|---|
| Glycopyrrolate | Synthetic; potent antisialagogue, no CNS/ophthalmic activity, longer duration (2-4 h vs 30 min for atropine) |
| Ipratropium | Inhaled bronchodilator; limited systemic absorption |
| Tiotropium | Long-acting inhaled; COPD |
| Propantheline | GI antispasmodic |
| Methscopolamine | Reduced CNS effects vs scopolamine |
| Clidinium | GI antispasmodic |
Structural basis: All are esters of an aromatic acid combined with an organic base. The ester linkage is essential for receptor binding. Quaternary amines carry a permanent positive charge, restricting BBB penetration.
2. By Source
| Source | Examples |
|---|---|
| Natural (belladonna alkaloids) | Atropine, Scopolamine, Hyoscine |
| Synthetic | Glycopyrrolate, Ipratropium, Tiotropium, Pirenzepine |
| Semi-synthetic | Methscopolamine |
3. By Receptor Selectivity
| Selectivity | Drug | Receptor Targeted | Clinical Use |
|---|---|---|---|
| Non-selective | Atropine, Scopolamine, Glycopyrrolate | M1, M2, M3 | General |
| M1-selective | Pirenzepine | M1 (gastric parietal cells) | Peptic ulcer |
| M3-selective | Darifenacin, Solifenacin | M3 (smooth muscle) | Overactive bladder |
| M2 > M3 | Tolterodine | M2, M3 | Overactive bladder |
4. By Clinical Application
| Use | Drug Examples |
|---|---|
| Preanesthetic / antisialagogue | Atropine, Scopolamine, Glycopyrrolate |
| Bradycardia / organophosphate poisoning | Atropine |
| COPD / Bronchospasm | Ipratropium, Tiotropium |
| Motion sickness / PONV | Scopolamine (transdermal) |
| Parkinson's disease | Benztropine, Trihexyphenidyl |
| Overactive bladder | Oxybutynin, Tolterodine, Solifenacin, Darifenacin |
| Peptic ulcer (GI) | Pirenzepine, Propantheline, Dicycloverine |
| Ophthalmology | Atropine, Tropicamide, Cyclopentolate |
| IBS / GI spasm | Hyoscine butylbromide (Buscopan), Clidinium |
5. Comparative Pharmacology of Classic Three
| Property | Atropine | Scopolamine | Glycopyrrolate |
|---|---|---|---|
| Structure | Tertiary amine | Tertiary amine | Quaternary amine |
| Tachycardia | +++ | + | ++ |
| Bronchodilation | ++ | + | ++ |
| Sedation/CNS | + | +++ | 0 |
| Antisialagogue | ++ | +++ | +++ |
| Crosses BBB | Yes | Yes | No |
| Duration | ~30 min (IV) | Longer | 2-4 h (IV) |
(0 = no effect; + = minimal; ++ = moderate; +++ = marked)
Mechanism of Action
Parasympatholytics competitively block muscarinic receptor subtypes:
- M1 - CNS, autonomic ganglia, gastric parietal cells
- M2 - Cardiac (SA node - bradycardia when blocked = tachycardia)
- M3 - Smooth muscle (bronchi, GI, bladder, pupil), glands
Anticholinergic Toxidrome ("Anticholinergic Syndrome")
Remembered by the classic mnemonics:
- "Red as a beet" - cutaneous vasodilation/flushing
- "Hot as a hare" - hyperthermia (anhidrosis)
- "Dry as a bone" - dry mucous membranes, no sweating
- "Blind as a bat" - mydriasis, cycloplegia
- "Mad as a hatter" - confusion, delirium (central effects)
- Plus: sinus tachycardia, urinary retention, ileus
Antidote: Physostigmine (crosses BBB; reverses both central and peripheral effects; avoid in tricyclic overdose due to risk of asystole)
Sources: Morgan and Mikhail's Clinical Anesthesiology, 7e, pp. 430-436; Katzung's Basic and Clinical Pharmacology, 16e, pp. 1623-1624
So I have to learn all of this right but in my book only the natural semi synthetic and synthetic classifications are given
Great question. If your book only gives the natural / semi-synthetic / synthetic classification, then that is your primary framework to learn. The other classifications (by receptor selectivity, by clinical use, tertiary vs quaternary) are supplementary knowledge that helps you understand the drugs better, but you won't be examined on frameworks your book doesn't cover.
Here's what to focus on:
Parasympatholytics - Classification by Origin
1. Natural (Belladonna Alkaloids)
- Atropine (hyoscyamine)
- Scopolamine (hyoscine)
2. Semi-synthetic
- Homatropine (from atropine)
- Methscopolamine (from scopolamine)
- Ipratropium (from atropine)
3. Synthetic
- Glycopyrrolate
- Propantheline
- Dicycloverine (Dicyclomine)
- Pirenzepine
- Tropicamide
- Oxybutynin
- Tolterodine
- Benztropine (some books list this as synthetic; others semi-synthetic)
Practical Tip
When studying, anchor each drug to one key clinical use - that way you learn classification + application together, rather than memorizing a bare list. For example:
| Drug | Class | Remember by |
|---|---|---|
| Atropine | Natural | Bradycardia, organophosphate poisoning |
| Scopolamine | Natural | Motion sickness, PONV |
| Ipratropium | Semi-synthetic | COPD inhaler |
| Glycopyrrolate | Synthetic | Preop (no CNS effects) |
| Pirenzepine | Synthetic | Peptic ulcer (M1 selective) |
| Oxybutynin | Synthetic | Overactive bladder |
Stick to your book's classification as the base - what you see in the previous answer is just the bigger picture to give you context.
Can you just tell me it's 5 o'clock action like not pharmacological action it's mechanism of action and its clinical use also and the side effect of it
Asking for Preferences
I mean mechanism of action of it
Finding Sources
Reading File
Finding Sources
I have enough from the textbooks. Here is everything clearly organized:
Parasympatholytics - MOA, Clinical Uses & Side Effects
Mechanism of Action
Parasympatholytics are esters of an aromatic acid + organic base. The ester linkage is what allows them to bind to muscarinic (ACh) receptors.
How it works - step by step:
- Drug binds to muscarinic receptors (M1, M2, M3)
- This is a competitive, reversible block - it competes with acetylcholine for the same receptor site
- ACh cannot bind → receptor is NOT activated
- The downstream cellular effects of ACh (mediated via second messengers like cGMP, IP3) are inhibited
- Result = parasympathetic effects are blocked → sympathetic tone dominates
Receptor subtypes blocked:
| Receptor | Location | Effect of blocking |
|---|---|---|
| M1 | CNS, gastric parietal cells, autonomic ganglia | Reduced gastric acid, CNS effects |
| M2 | Heart (SA node) | Tachycardia |
| M3 | Smooth muscle, glands, pupils | Bronchodilation, dry mouth, mydriasis, urinary retention |
Clinical Uses
| Use | Drug of Choice | Why |
|---|---|---|
| Preanesthetic (dry secretions) | Glycopyrrolate, Scopolamine | Potent antisialagogue |
| Bradycardia | Atropine | Most potent cardiac effect |
| Organophosphate/nerve gas poisoning | Atropine | Reverses muscarinic overstimulation |
| COPD / Bronchospasm | Ipratropium | Bronchodilation via M3 block |
| Motion sickness / PONV | Scopolamine (transdermal) | CNS M1 block |
| Parkinson's disease | Benztropine, Trihexyphenidyl | Reduces cholinergic overactivity |
| Overactive bladder | Oxybutynin, Tolterodine | M3 block in detrusor muscle |
| Peptic ulcer | Pirenzepine | Selective M1 - reduces gastric acid |
| Ophthalmology (mydriasis/cycloplegia) | Atropine, Tropicamide | M3 block in iris/ciliary muscle |
| IBS / GI spasm | Hyoscine butylbromide (Buscopan) | Smooth muscle relaxation |
Side Effects
All side effects are basically "too much blocking" of parasympathetic activity:
| System | Side Effect |
|---|---|
| Heart | Tachycardia, palpitations |
| Eyes | Mydriasis (dilated pupils), cycloplegia (blurred vision), photophobia |
| Mouth/Secretions | Dry mouth, dry eyes, reduced bronchial secretions |
| Skin | Flushing, dry skin, anhidrosis (no sweating) |
| Temperature | Hyperthermia / "atropine fever" (no sweating = can't cool down) |
| GI | Constipation, reduced bowel motility, ileus |
| Urinary | Urinary retention (especially in elderly males with BPH) |
| CNS (tertiary amines only) | Confusion, delirium, hallucinations, sedation (scopolamine), restlessness |
| Eyes (dangerous) | Can precipitate acute angle-closure glaucoma |
The Classic Toxicity Mnemonic
"Red as a beet" - flushing "Hot as a hare" - hyperthermia "Dry as a bone" - no secretions/sweat "Blind as a bat" - mydriasis + cycloplegia "Mad as a hatter" - delirium/confusion
Antidote for overdose: Physostigmine (a cholinesterase inhibitor that crosses the BBB - reverses both central and peripheral effects)
Source: Morgan and Mikhail's Clinical Anesthesiology, 7e, pp. 430-436
Can you explain me all these four terms the first one is para sympathemiatic second one is para sympatholytic that heard one is sympathomimetic and fourth one is sympatholytic
Great foundational question. Let me break down the word meanings first, then the pharmacology.
Word Breakdown (understand the logic)
| Part | Meaning |
|---|---|
| Parasympathetic | The "rest and digest" division of ANS |
| Sympathetic | The "fight or flight" division of ANS |
| -mimetic | Mimics / imitates / activates |
| -lytic | Blocks / destroys / inhibits |
So just by the name you already know what each drug does:
The Four Terms - Simply Explained
1. Parasympathomimetic
= Mimics the parasympathetic system
- These drugs activate muscarinic (and sometimes nicotinic) receptors
- Produce the same effects as ACh / parasympathetic stimulation
- Also called cholinergic drugs
Effects (SLUDD):
- Salivation increased
- Lacrimation increased
- Urination increased
- Defecation / GI motility increased
- Diaphoresis (sweating)
- Also: bradycardia, bronchoconstriction, miosis (pupil constriction)
Examples:
- Direct: Pilocarpine, Carbachol, Bethanechol, Muscarine
- Indirect (anticholinesterase): Neostigmine, Physostigmine, Organophosphates
2. Parasympatholytic
= Blocks / lyses the parasympathetic system
- These drugs block muscarinic receptors
- Prevent ACh from binding → parasympathetic effects are inhibited
- Also called anticholinergic / antimuscarinic drugs
Effects (opposite of SLUDD):
- Dry mouth, dry eyes
- Tachycardia
- Bronchodilation
- Mydriasis (dilated pupils)
- Urinary retention, constipation
- CNS: confusion, sedation
Examples: Atropine, Scopolamine, Glycopyrrolate, Ipratropium
3. Sympathomimetic
= Mimics the sympathetic system
- These drugs activate adrenergic receptors (alpha and/or beta)
- Produce the same effects as adrenaline (epinephrine) / sympathetic stimulation
- Also called adrenergic agonists
Effects (Fight or Flight):
- Tachycardia, increased BP
- Bronchodilation
- Mydriasis
- Reduced GI motility
- Vasoconstriction (alpha) or vasodilation (beta2)
- Increased blood glucose
Examples: Adrenaline (Epinephrine), Noradrenaline, Dopamine, Salbutamol, Phenylephrine, Dobutamine
4. Sympatholytic
= Blocks / lyses the sympathetic system
- These drugs block adrenergic receptors OR reduce noradrenaline release
- Prevent sympathetic effects
- Also called adrenergic antagonists / blockers
Effects (opposite of fight or flight):
- Bradycardia, decreased BP
- Bronchoconstriction (beta blockers)
- Vasodilation
- Reduced cardiac output
Examples: Propranolol (beta blocker), Atenolol, Prazosin (alpha blocker), Clonidine (central sympatholytic)
Summary Table - The Big Picture
| Term | ANS Division | Action | Neurotransmitter Involved | Also Called |
|---|---|---|---|---|
| Parasympathomimetic | Parasympathetic | Activates | ACh (muscarinic) | Cholinergic agonist |
| Parasympatholytic | Parasympathetic | Blocks | ACh (muscarinic) | Anticholinergic / Antimuscarinic |
| Sympathomimetic | Sympathetic | Activates | Adrenaline / NA (adrenergic) | Adrenergic agonist |
| Sympatholytic | Sympathetic | Blocks | Adrenaline / NA (adrenergic) | Adrenergic antagonist |
One Line Memory Trick
"-mimetic" = same as the system (agonist) "-lytic" = opposite of the system (antagonist)
So if you see any drug ending in or described as "-mimetic" → it activates that system. If "-lytic" → it blocks that system. Simple as that.
But if I know correctly the paralytic is not anticol energy I think you should research in this week doesn't block the action of acetylcholine its block the action of enzyme which break acetylcholine
You're mixing up two different drug classes here. Let me clarify directly:
You Are Describing TWO Different Things
What you described:
"Blocks the enzyme that breaks down ACh"
That is anticholinesterase drugs (also called cholinesterase inhibitors) - they block acetylcholinesterase, the enzyme that breaks down ACh. Because ACh is NOT broken down, it accumulates and keeps stimulating receptors.
- Examples: Neostigmine, Physostigmine, Organophosphates
- Effect: MORE ACh activity → parasympathomimetic effect
- So these are actually parasympathomimetics (indirect acting)
What parasympatholytic actually is:
Parasympatholytics (anticholinergics) directly block the muscarinic receptor itself - ACh is still produced and released, but it cannot bind to the receptor because the drug is sitting on it.
Simple Comparison
| Drug Type | What it blocks | Effect on ACh | Final Effect |
|---|---|---|---|
| Parasympatholytic (e.g. Atropine) | Muscarinic receptor | ACh produced normally, but cannot bind | Blocks parasympathetic |
| Anticholinesterase (e.g. Neostigmine) | Acetylcholinesterase enzyme | ACh accumulates (not broken down) | Mimics/enhances parasympathetic |
So to be very clear:
- Parasympatholytic ≠ blocks the enzyme
- Parasympatholytic = blocks the receptor
- The drug that blocks the enzyme is the opposite - it is a parasympathomimetic (indirect acting)
Your logic was actually correct pharmacology - you just applied it to the wrong drug class. The enzyme-blocking drugs belong under parasympathomimetics, not parasympatholytics.
Okay I got it
Great! That's a really common point of confusion and you were thinking in the right direction - you just had the category switched.
Quick recap to lock it in:
- Blocks receptor → Parasympatholytic (Atropine)
- Blocks enzyme → Parasympathomimetic indirect (Neostigmine)
If you have more questions as you study, just ask. Good luck! 👍
This is a shared conversation. Sign in to Orris to start your own chat.